-
A long-time patient, who is a 56-year-old male, arrives for his annual exam complaining of excessive thirst, frequent urination, unplanned weight gain, and fatigue. His blood pressure, which was borderline hypertensive last year, is now 160/95. He reports no change in diet, job responsibilities, or family life. This year, you have added another screening to the standard vital signs.
-
In a retrospective review of consecutive patients with colon cancer, the presence of diabetes mellitus was found to confer negative prognostic information with regard to overall, and cancer-specific, survival. Notably, it was in patients with stage II disease that the presence of diabetes was of most importance.
-
A trial undertaken by EORTC was designed to determine if neoadjuvant chemotherapy would be successful in the absence of post-surgical chemotherapy in enhancing overall survival in patients with locally advanced gastric cancer. The trial did not accrue sufficient numbers of patients to demonstrate a survival benefit. However, presurgical chemotherapy was associated with a higher rate of complete resection and fewer positive lymph nodes, features that suggest progression-free and overall survival might be favorably affected.
-
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
The U.S. Food and Drug Administration (FDA) has recently approved denosumab for the prevention of skeletal-related events in patients with bone metastases from solid tumors.
-
A 74-year retired veterinarian presents to the emergency department (ED) with shortness of breath. He was recently diagnosed with diffuse large-cell lymphoma with prominent abdominal lymphadenopathy and positive bone marrow and has been treated with two cycles of R-CHOP.
-
-
Intraoperative placement of adhesion barriers has been a long-practiced adjuvant to major abdominal/pelvic surgery in an attempt to reduce postoperative complications such as bowel obstruction and infertility.
-
A Single Umbilical Artery (SUA) is found in about 1 in 200 fetuses in the second trimester. Since the finding is associated with an increase in fetal anomalies, it alerts clinicians to search for any of the possible abnormalities linked with this finding.
-
Lewis and colleagues performed an investigator-blinded study of sperm penetrability and quality of mid-cycle cervical mucus between levonorgestrel-releasing intrauterine device (LNG-IUD) users (n = 14) and hormone-free controls (n = 16).